As part of World Immunization Week 2026, the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health is bringing together a distinguished panel of experts to explore strategies and approaches to increase vaccination coverage and access across the life course, from infants and young children to adolescents, pregnant women, and adults. The webinar will conclude with a moderated Q&A session to answer participant questions.  

Join the Secure PCV experts as they launch their first report outlining the opportunities now available to countries to rapidly improve the impact of pneumonia vaccination programs in the context of tight budgets.

The global HPV vaccination landscape has shifted from a period of scarcity to one of strategic opportunity. While girls aged 9–14 remain the global priority, achieving high coverage requires moving beyond a "one-size-fits-all" model to address the deep diversity within and across groups. First, ensuring that all girls are reached, including those out-of-school or in marginalized communities, demands local, contextual adaptations rooted in the lived experiences of the users themselves. As countries stabilize these core programs, they face a new strategic horizon: the inclusion of "secondary" populations, namely older girls and boys. Expanding these cohorts is not merely a matter of increasing supply; it requires navigating political and cultural landscapes, resource shifts, and delivery adaptations to fully address the needs of each population group.

This webinar explores learnings across the programmatic spectrum, from user-centric insights to national-scale implementation. We begin with a deep dive into a Human-Centered Design (HCD) study that elevates and centers the voices of girls as primary users. Building on this foundation, we present studies focused on "secondary" populations: a review of reaching older girls and expanding to Gender-Neutral Vaccination in low-and-middle-income countries. The session culminates in a high-level panel of country representatives who will share practical programmatic adaptations for each of these three distinct groups. Participants will walk away with a nuanced understanding of how to maintain a girl-centered core while successfully navigating the logistical and political shifts necessary for a truly inclusive HPV vaccine program.